Charles M. Lieber

Charles M. Lieber, born on April ninth, nineteen fifty-nine, is a prominent American chemist, inventor, and nanotechnologist. Renowned for his groundbreaking work in the synthesis, assembly, and characterization of nanoscale materials and devices, Lieber has significantly advanced the field of nanoscience. His contributions extend to the application of nanoelectronic devices in biology, and he has played a pivotal role as a mentor to many leaders in the discipline.

Previously a professor at Harvard University, Lieber held the esteemed position of chair of the department of chemistry and chemical biology, while also serving as the Joshua and Beth Friedman University Professor. With over four hundred published papers in peer-reviewed journals and numerous contributions to books on nanoscience, his academic influence is profound. In two thousand eleven, he was recognized by Thomson Reuters as the leading chemist of the decade from two thousand to two thousand ten, highlighting the impact of his scientific publications.

Lieber's entrepreneurial spirit led him to co-found the nanotechnology company Nanosys in two thousand one and Vista Therapeutics in two thousand seven. His innovative work earned him the Wolf Prize in Chemistry in two thousand twelve, awarded in a special ceremony at the Israeli Knesset. However, his career faced significant challenges when he was arrested by the FBI in two thousand twenty, leading to a conviction in December two thousand twenty-one on multiple felony charges related to false statements and tax returns.

Since his arrest, Lieber has been on paid leave from Harvard due to his legal issues and a lymphoma diagnosis. In April two thousand twenty-five, he transitioned to a new role as a full-time chair professor at Tsinghua Shenzhen International Graduate School in China, while also serving as a SMART Investigator at the Shenzhen Medical Academy of Research and Translation.